IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 294 10.54660/IJMBHR.2022.3.1.73-82 Enhancing biopharmaceutical supply chains: Strategies for efficient drug formulary development in emerging markets OgbuaguOluchukwu Obinna MbataAkachukwu Obianuju BalogunObe Destiny OladapoOlajumoke OjoOpeyemi Olaoluawa MuondeMuridzo Sanofil, Nigeria Kaybat Pharmacy and Stores, Benin, Nigeria Independent Researcher, Lima Ohio, USA Health Mark Regional Medical Center Florida, USA Medical Statistician, University of Medical Science Teaching Hospital Ondo, Nigeria Africure Pharmaceuticals Namibia 2022 3 1 73 82 12012022 13022022 CC BY-NC-SA 4.0

Biopharmaceutical supply chains in emerging markets face numerous challenges that hinder the efficient development and distribution of essential medicines. These challenges include regulatory barriers, infrastructure deficiencies, logistical inefficiencies, and market volatility. This paper explores strategic approaches to optimizing drug formulary development within these contexts, highlighting the importance of data-driven decision-making, regulatory harmonization, and public-private partnerships. The research also discusses technological innovations, such as blockchain, IoT, and automation, which can enhance supply chain operations' transparency, traceability, and efficiency. By identifying these challenges and proposing actionable solutions, this paper offers recommendations for policymakers, industry leaders, and healthcare providers to strengthen supply chains and improve access to life-saving drugs. Future research directions are also outlined, focusing on the role of digital transformation, sustainable supply chain models, and regulatory advancements. Ultimately, this paper aims to contribute to the ongoing efforts to enhance drug formulary development and supply chain efficiency, ensuring equitable access to affordable medicines in emerging markets.

 Biopharmaceutical supply chainsdrug formulary developmentregulatory harmonizationpublic-private partnershipstechnological innovationssustainable procurement References Abbott KW, Snidal D. The governance triangle: Regulatory standards institutions and the shadow of the state. In: The spectrum of international institutions. Routledge; c2021. p. 52-91. Abdulmalek S, Nasir A, Jabbar WA, Almuhaya MA, Bairagi AK, Khan MA-M, et al. IoT-based healthcare-monitoring system towards improving quality of life: A review. Paper presented at: Healthcare; c2022. Algorri M, Abernathy MJ, Cauchon NS, Christian TR, Lamm CF, Moore CM. Re-envisioning pharmaceutical manufacturing: increasing agility for global patient access. J Pharm Sci. 2022;111(3):593-607. Bamakan SMH, Moghaddam SG, Manshadi SD. Blockchain-enabled pharmaceutical cold chain: Applications, key challenges, and future trends. J Clean Prod. 2021;302:127021. Berdud M, Chalkidou K, Dean EB, Ferraro J, Garrison L, Nemzoff C, et al. The future of global health procurement: issues around pricing transparency. Burns L, Le Roux N, Kalesnik-Orszulak R, Christian J, Hukkelhoven M, Rockhold F, et al. Real-world evidence for regulatory decision-making: guidance from around the world. Clin Ther. 2022;44(3):420-437. Buxton J, Bingham T. The rise and challenge of dark net drug markets. Policy brief. 2015;7(2):1-24. Calder A. Assessment of potential barriers to medicines regulatory harmonization in the Southern African Development Community (SADC) region. 2016. Chung YH, Church D, Koellhoffer EC, Osota E, Shukla S, Rybicki EP, et al. Integrating plant molecular farming and materials research for next-generation vaccines. Nat Rev Mater. 2022;7(5):372-388. Dhaliwal A. The rise of automation and robotics in warehouse management. In: Transforming Management Using Artificial Intelligence Techniques. CRC Press; c2020. p. 63-72. Dhiman SK, Gummadi V, Dureja H. Partnership efforts– Their potential to reduce the challenges that confront regulators and pharmaceutical industry. Appl Clin Res Clin Trials Regul Aff. 2019;6(1):7-17. Ding B. Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Saf Environ Prot. 2018;119:115-130. Dinh H. The Revolution of Warehouse Inventory Management by Using Artificial Intelligence: Case Warehouse of Company X. 2020. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Edoh NL, Ukpabi UJ, Igol JO. Untargeted metabolomics profiling of high beta carotene cassava with respect to postharvest physiological deterioration. 2021. Edoh NL, Ukpabi UJ, Igoli JO. Effect of scopoletin and carotenoids on postharvest physiological deterioration (PPD) of transgenic high beta carotene cassava. J Food Res. 2021;10(4):1-9. Gillespie JJ, Privitera GJ, Gaspero J. Biopharmaceutical entrepreneurship, open innovation, and the knowledge economy. J Innov Manag. 2019;7(2):59-77. Harrison RP, Ruck S, Medcalf N, Rafiq Q A. Decentralized manufacturing of cell and gene therapies: Overcoming challenges and identifying opportunities. Cytotherapy. 2017;19(10):1140-1151. Hirsch G, Trusheim M, Cobbs E, Bala M, Garner S, Hartman D, et al. Adaptive biomedical innovation: evolving our global system to sustainably and safely bring new medicines to patients in need. Clin Pharmacol Ther. 2016;100(6):685-698. Ibrahim T, Araujo CA. Biopharmaceutical supply chain challenges in developing countries: an exploratory analysis. Paper presented at: Supply Chain Forum: An Int J; c2021. Koçkaya G, Wertheimer A. Pharmaceutical market access in emerging markets: SEEd. 2016. Kohler JC, Martinez MG, Petkov M, Sale J. Corruption in the pharmaceutical sector: diagnosing the challenges. 2016. Ma J-Y, Shi L, Kang T-W. The effect of digital transformation on the pharmaceutical sustainable supply chain performance: The mediating role of information sharing and traceability using structural equation modeling. Sustainability. 2022;15(1):649. Mackey TK, Nayyar G. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opin Drug Saf. 2017;16(5):587-602. Masheti C. E-procurement practices and operational performance of pharmaceutical manufacturing firms in Nairobi. University of Nairobi; c2016. Mello MM. What makes ensuring access to affordable prescription drugs the hardest problem in health policy. Minn L Rev. 2017;102:2273. Myles L, Church TD. An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies. Cytotherapy. 2022;24(3):344-355. Neumann PJ, Cohen JT, Ollendorf DA. The right price: a value-based prescription for drug costs. Oxford University Press; c2021. Nguyen A, Lamouri S, Pellerin R, Tamayo S, Lekens B. Data analytics in pharmaceutical supply chains: state of the art, opportunities, and challenges. Int J Prod Res. 2022;60(22):6888-6907. Organization WH. China policies to promote local production of pharmaceutical products and protect public health. World Health Organization; c2017. Organization WH. Technical report: pricing of cancer medicines and its impacts: a comprehensive technical report for the World Health Assembly Resolution 70.12: operative paragraph 2.9 on pricing approaches and their impacts on availability and affordability of medicines for the prevention and treatment of cancer. 2018. Ozkan N. Fostering Digital Marketplaces in Logistics and Supply Chain: Trends and Opportunities. Politecnico di Torino; c2020. Panda SK, Satapathy SC. Drug traceability and transparency in medical supply chain using blockchain for easing the process and creating trust between stakeholders and consumers. Pers Ubiquitous Comput. 2021;1-17. Pojani D, Stead D. Sustainable urban transport in the developing world: beyond megacities. Sustainability. 2015;7(6):7784-7805. Pojani D, Stead D. The urban transport crisis in emerging economies: An introduction. Springer; c2017. Ragavan S, Vanni A. Intellectual property law and access to medicines: TRIPS agreement, health, and pharmaceuticals. Taylor & Francis; c2021. Sarkis M, Bernardi A, Shah N, Papathanasiou MM. Emerging challenges and opportunities in pharmaceutical manufacturing and distribution. Processes. 2021;9(3):457. Seyedan M, Mafakheri F. Predictive big data analytics for supply chain demand forecasting: methods, applications, and research opportunities. J Big Data. 2020;7(1):53. Shankar V, Grewal D, Sunder S, Fossen B, Peters K, Agarwal A. Digital marketing communication in global marketplaces: A review of extant research, future directions, and potential approaches. Int J Res Mark. 2022;39(2):541-565. Sharma DK, Gupta P. Internet of Things: The new Rx for pharmaceutical manufacturing and supply chains. In: An Industrial IoT Approach for Pharmaceutical Industry Growth. Elsevier; c2020. p. 257-288. Shashi M. Digital Strategies to improve the performance of pharmaceutical supply chains. Walden University; c2022. Singh RK, Kumar R, Kumar P. Strategic issues in pharmaceutical supply chains: a review. Int J Pharm Healthcare Mark. 2016;10(3):234-257. Smyth SJ, Webb SR, Phillips PW. The role of public-private partnerships in improving global food security. Global Food Sec. 2021;31:100588. Sople VV. Managing intellectual property: The strategic imperative. PHI Learning Pvt. Ltd.; c2016. Sun Y, Ali SI. Internet of things (IoT) and blockchain applications in pharmaceutical supply chain provenance to achieve traceability, transparency, and authenticity. In: Advancing Smarter and More Secure Industrial Applications Using AI, IoT, and Blockchain Technology. IGI Global; c2022. p. 1-36. Tusé D, Nandi S, McDonald KA, Buyel JF. The emergency response capacity of plant-based biopharmaceutical manufacturing-what it is and what it could be. Front Plant Sci. 2020;11:594019. Vogler S, Zimmermann N, Haasis A, Babar-Ud-Din Z, Busse R, Espin Balbino J. Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? From diagnosis to sustainable impact. Editorial. 2019. Wang Y, Kung L, Wang WY-C, Cegielski CG. An integrated big data analytics-enabled transformation model: Application to health care. Inf Manag. 2018;55(1):64-79. Winegarden W. Improving market efficiencies will promote greater drug affordability. Pacific Research International Journal of Medical and All Body Health Research www.allmedicaljournal.com Institute; c2 020. Available from: https://www.pacificresearch.org/wp. Yoo S-L, Kim D-J, Lee S-M, Kang W-G, Kim S-Y, Lee JH, et al. Improving patient access to new drugs in South Korea: evaluation of the national drug formulary system. Int J Environ Res Public Health. 2019;16(2):288. Zhu X, Ninh A, Zhao H, Liu Z. Demand forecasting with supply‐chain information and machine learning: Evidence in the pharmaceutical industry. Prod Oper Manag. 2021;30(9):3231-3252.